[
  {
    "date": "2023-12-30",
    "symbol": "VRCA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VRCA",
    "entityinteractivedatacurrent": "Yes",
    "entityregistrantname": "Verrica Pharmaceuticals Inc.",
    "entitycentralindexkey": 1660334,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-38529",
    "entitytaxidentificationnumber": "46-3137900",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "44 West Gay Street",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "West Chester",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19380,
    "cityareacode": 484,
    "localphonenumber": "453-3300",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Philadelphia, PA",
    "auditorfirmid": 185,
    "documentfinstmterrorcorrectionflag": "false",
    "cashandcashequivalentsatcarryingvalue": 69547000,
    "accountsreceivablenetcurrent": 4248000,
    "unbilledreceivablescurrent": 168000,
    "inventorynet": 1022000,
    "prepaidexpenseandotherassetscurrent": 2545000,
    "assetscurrent": 77530000,
    "propertyplantandequipmentnet": 1052000,
    "operatingleaserightofuseasset": 1158000,
    "financeleaserightofuseasset": 1405000,
    "otherassetsnoncurrent": 452000,
    "assets": 81597000,
    "accountspayablecurrent": 2464000,
    "accruedexpensesandothercurrentliabilities": 13860000,
    "operatingleaseliabilitycurrent": 324000,
    "financeleaseliabilitycurrent": 376000,
    "liabilitiescurrent": 17024000,
    "operatingleaseliabilitynoncurrent": 910000,
    "financeleaseliabilitynoncurrent": 1026000,
    "longtermdebt": 42874000,
    "liabilities": 61834000,
    "commonstockvalue": 4000,
    "additionalpaidincapitalcommonstock": 250207000,
    "retainedearningsaccumulateddeficit": -230448000,
    "stockholdersequity": 19763000,
    "liabilitiesandstockholdersequity": 81597000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 42518697,
    "commonstocksharesoutstanding": 42413553,
    "treasurystockcommonshares": 105144,
    "revenuefromcontractwithcustomerexcludingassessedtax": 4658000,
    "sellinggeneralandadministrativeexpense": 47305000,
    "researchanddevelopmentexpense": 20295000,
    "gainlossondispositionofassets1": -2537000,
    "costofproductrevenue": 289000,
    "costofcollaborationrevenue": 457000,
    "operatingexpenses": 70883000,
    "operatingincomeloss": -65759000,
    "investmentincomeinterest": 2740000,
    "interestexpense": 3962000,
    "othernonoperatingincomeexpense": -14000,
    "nonoperatingincomeexpense": -1236000,
    "earningspersharebasic": -1.48,
    "earningspersharediluted": -1.48,
    "weightedaveragenumberofsharesoutstandingbasic": 45342451,
    "weightedaveragenumberofdilutedsharesoutstanding": 45342451,
    "netincomeloss": -66995000,
    "comprehensiveincomenetoftax": -66995000,
    "sharesissued": 42518697,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 14376000,
    "stockissuedduringperiodvaluenewissues": 30301000,
    "stockissuedduringperiodsharesnewissues": 750000,
    "debtconversionconvertedinstrumentamount1": 2041000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 561500,
    "stockissuedduringperiodvaluestockoptionsexercised": 7000,
    "stockissuedduringperiodsharesstockoptionsexercised": 8000,
    "profitloss": -66995000,
    "allocatedsharebasedcompensationexpense": 14376000,
    "depreciation": 530000,
    "noncashinterestexpense": 810000,
    "gainlossondispositionofassets": -2537000,
    "operatingleaserightofuseassetamortizationexpense": 286000,
    "financeleaserightofuseassetamortization": 20000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -587000,
    "increasedecreaseinaccountspayable": 2201000,
    "increasedecreaseinaccountsreceivable": 3860000,
    "increasedecreaseinunbilledreceivable": 69000,
    "increasedecreaseinaccruedexpensesandothercurrentliabilities": 11291000,
    "increasedecreaseinoperatingleaseliability": -291000,
    "netcashprovidedbyusedinoperatingactivities": -38577000,
    "paymentstoacquirepropertyplantandequipment": 362000,
    "netcashprovidedbyusedininvestingactivities": -362000,
    "proceedsfromstockoptionsexercised": 7000,
    "proceedsfromdebtnetofissuancecosts": 44105000,
    "proceedsfromissuanceofcommonstockandprefundedwarrantsnetofissuancecosts": 30300000,
    "equityissuancecosts": 177000,
    "financeleaseprincipalpayments": 23000,
    "netcashprovidedbyusedinfinancingactivities": 74213000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 35274000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 69547000,
    "interestpaidnet": 3152000,
    "noncashorpartnoncashacquisitionvalueofassetsacquired1": 93000,
    "rightofuseassetobtainedinexchangeforleaseobligation": 1428000,
    "classofwarrantorrightoutstanding": 4064814,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.0001,
    "numberofoperatingsegments": 1,
    "interestbearingdepositsinbanks": 500000000,
    "basicexerciseprice": 0.0001,
    "dilutedexerciseprice": 0.0001,
    "advertisingexpense": 3500000,
    "costofrevenue": 500000,
    "inventoryfinishedgoods": 115000,
    "impairmentoflonglivedassetstobedisposedof": 2600000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeTermOfLeaseMember",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5565615,
    "propertyplantandequipmentgross": 1543000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1174000,
    "inventoryrawmaterials": 420000,
    "inventoryworkinprocess": 487000,
    "operatingcostsandexpenses": 60000,
    "feepereligiblepatient": 15000,
    "otherliabilities": 10000,
    "patientexpenses": 400000,
    "grosstonetreserves": 5357000,
    "employeerelatedliabilitiescurrent": 3438000,
    "accruedclinicaltrialanddrugdevelopmentcurrent": 2767000,
    "accruedprofessionalfeescurrent": 1423000,
    "commercialrelatedcosts": 538000,
    "otherliabilitiescurrent": 244000,
    "accruedmachineryandequipment": 93000,
    "longtermpurchasecommitmentperiod": "P5Y",
    "purchasecommitmentamountcommitted": 700000,
    "prepaidexpensecurrentandnoncurrent": 700000,
    "warrantsandrightsoutstandingmaturitydate": "2033-07-25",
    "commonstockcapitalsharesreservedforfutureissuance": 3738199,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofyearsforwhichpercentageincrease": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageappliedonoutstandingsharesofcommonstockforautomaticallyincreaseoneachyear": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2419919,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P12M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionvestingterm": "through 2026",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationterm": "through 2033",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.07,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 12000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 561500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 9.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 698000,
    "employeeservicesharebasedcompensationallocationofrecognizedperiodcostscapitalizedamount": 8800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1500000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0357,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0476,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.9309,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.9594,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5565615,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1760836,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedandexpiredinperiod": -120000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 3081357,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.25,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.9,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeitureandexpiredinperiodweightedaverageexerciseprice": 5.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 9.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P5Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4143150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 1810191000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 561500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 9.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.58,
    "leaseagreementcommencementdate": "2022-05-01",
    "areaofofficespaceforlease": 11201,
    "leaseexpirationdate1": "2027-09-01",
    "operatingleasebaserentexpense": 2400000,
    "financeleaseliability": 1400000,
    "operatingleaseliability": 1234000,
    "lesseefinanceleasetermofcontract1": "P52M",
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y6M29D",
    "financeleaseweightedaverageremainingleaseterm1": "P4Y3M7D",
    "operatingleaseweightedaveragediscountratepercent": 0.0625,
    "financeleaseweightedaveragediscountratepercent": 0.0787,
    "financeleaserightofuseassetamortization1": 23000,
    "financeleaseinterestexpense": 7000,
    "financeleasecost": 30000,
    "operatingleasecost": 282000,
    "operatingleaseexpense": 282000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 390000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 372000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 366000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 247000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1375000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 141000,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 470000,
    "financeleaseliabilitypaymentsdueyeartwo": 402000,
    "financeleaseliabilitypaymentsdueyearthree": 343000,
    "financeleaseliabilitypaymentsdueyearfour": 324000,
    "financeleaseliabilitypaymentsdueafteryearfour": 83000,
    "financeleaseliabilitypaymentsdue": 1622000,
    "financeleaseliabilityundiscountedexcessamount": 220000,
    "additiontolineofcreditfacilitycommitmentfeeamount": 250000000,
    "deferredfinancecostsnet": 5900000,
    "debtinstrumentcarryingamount": 2500000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 9626000,
    "interestexpensedebt": 4000000,
    "interestexpensedebtexcludingamortization": 3200000,
    "amortizationoffinancingcosts": 800000,
    "shorttermborrowings": 50000000,
    "accruedfinalpaymentfee": 2500000,
    "debtcurrent": 42874000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -14069000,
    "incometaxreconciliationstateandlocalincometaxes": -1547000,
    "incometaxreconciliationpermanentitems": 1063000,
    "incometaxreconciliationtaxcreditsresearch": 466000,
    "incometaxreconciliationchangeinenactedtaxrate": 482000,
    "incometaxreconciliationotheradjustments": 585000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 13952000,
    "deferredtaxassetsoperatinglosscarryforwards": 37167000,
    "deferredtaxassetssection174capitalization": 5150000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4690000,
    "deferredtaxassetstaxcreditcarryforwards": 3081000,
    "deferredtaxassetsaccruedcompensation": 803000,
    "deferredtaxassetsamortization": 673000,
    "deferredtaxassetsleaseliabilities": 619000,
    "deferredtaxassetsother": 2122000,
    "deferredtaxassetsgross": 54305000,
    "deferredtaxassetsvaluationallowance": 53684000,
    "deferredtaxassetsnet": 621000,
    "deferredtaxliabilitiesrightofuseassets": 601000,
    "deferredtaxliabilitiespropertyplantandequipment": 20000,
    "deferredincometaxliabilities": 621000,
    "operatinglosscarryforwards": 149600000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "equitymethodinvestmentownershippercentage": 0.5,
    "equitymethodinvestmentownershipperiod": "P3Y",
    "billedcollaborationrevenue": 500000,
    "unbilledcollaborationrevenue": 1000000
  },
  {
    "date": "2022-12-30",
    "symbol": "VRCA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": " December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VRCA",
    "entityinteractivedatacurrent": "Yes",
    "entityregistrantname": "Verrica Pharmaceuticals Inc.",
    "entitycentralindexkey": 1660334,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "true",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-38529",
    "entitytaxidentificationnumber": "46-3137900",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "The Nasdaq Stock Market, LLC",
    "documentannualreport": "☒ ",
    "documenttransitionreport": "☐ ",
    "entityincorporationstatecountrycode": "Delaware",
    "entityaddressaddressline1": "44 West Gay Street",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "West Chester",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19380,
    "cityareacode": 484,
    "localphonenumber": "453-3300",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Philadelphia, PA",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": 34273000,
    "collaborationrevenuereceivable": 388000,
    "unbilledreceivablescurrent": 99000,
    "prepaidexpenseandotherassetscurrent": 4355000,
    "assetscurrent": 39115000,
    "propertyplantandequipmentnet": 3887000,
    "operatingleaserightofuseasset": 99000000,
    "otherassetsnoncurrent": 276000,
    "assets": 44721000,
    "accountspayablecurrent": 507000,
    "accruedexpensesandothercurrentliabilities": 2655000,
    "operatingleaseliabilitycurrent": 297000,
    "liabilitiescurrent": 3459000,
    "operatingleaseliabilitynoncurrent": 1229000,
    "liabilities": 4688000,
    "commonstockvalue": 4000,
    "additionalpaidincapitalcommonstock": 203482000,
    "retainedearningsaccumulateddeficit": -163453000,
    "stockholdersequity": -163453000,
    "liabilitiesandstockholdersequity": 44721000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "treasurystockshares": 105144,
    "revenuefromcontractwithcustomerexcludingassessedtax": 9032000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTax",
    "researchanddevelopmentexpense": 1000000,
    "generalandadministrativeexpense": 17405000,
    "costofcollaborationrevenue": 725000,
    "operatingexpenses": 30328000,
    "operatingincomeloss": -21296000,
    "investmentincomeinterest": 476000,
    "interestexpense": 2172000,
    "gainslossesonextinguishmentofdebt": -1437000,
    "othernonoperatingincomeexpense": -58000,
    "nonoperatingincomeexpense": -3191000,
    "netincomeloss": -24487000,
    "earningspersharebasic": -0.72,
    "earningspersharediluted": -0.72,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 29000,
    "comprehensiveincomenetoftax": -24458000,
    "sharesissued": 105144,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4985000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluenewissues": 26901000,
    "profitloss": -24487000,
    "allocatedsharebasedcompensationexpense": 3525000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -108000,
    "depreciation": 454000,
    "noncashinterestexpense": 383000,
    "operatingleaserightofuseassetamortizationexpense": 264000,
    "gainlossonterminationoflease": -6000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 456000,
    "increasedecreaseincollaborationreceivablebilledandunbilled": 487000,
    "increasedecreaseinaccountspayable": -338000,
    "increasedecreaseinaccruedexpensesandothercurrentliabilities": -255000,
    "increasedecreaseinoperatingleaseliability": -264000,
    "netcashprovidedbyusedinoperatingactivities": -18650000,
    "paymentstoacquiremarketablesecurities": 4485000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 59008000,
    "paymentstoacquirepropertyplantandequipment": 302000,
    "increasedecreaseindepositsinvestingactivity": 180000,
    "netcashprovidedbyusedininvestingactivities": 54041000,
    "proceedsfromissuanceofcommonstock": 26901000,
    "paymentsofdebtissuancecosts": 17000,
    "paymentsofdebtextinguishmentcosts": 43750000,
    "financeleaseprincipalpayments": 4000,
    "netcashprovidedbyusedinfinancingactivities": -16870000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 18521000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 34273000,
    "noncashorpartnoncashacquisitionvalueofassetsacquired1": 167000,
    "rightofuseassetobtainedinexchangeforleaseobligation": 99000,
    "marketablesecuritiesunrealizedgainloss": 29000,
    "interestpaidnet": 1789000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "3 years",
    "propertyplantandequipmentestimatedusefullives": "Lease Term",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "propertyplantandequipmentgross": 4586000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 699000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 24000,
    "employeerelatedliabilitiescurrent": 1399000,
    "accruedclinicaltrialanddrugdevelopmentcurrent": 974000,
    "accruedconstructioninprocesscurrent": 167000,
    "accruedprofessionalfeescurrent": 58000,
    "accruedmachineryandequipment": 57000,
    "longtermpurchasecommitmentperiod": "five-year",
    "purchasecommitmentamountcommitted": 700000,
    "purchasecommitmentprepayment": 700000,
    "prepaidexpensecurrentandnoncurrent": 1500000,
    "commonstockvotingrights": "one",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofyearsforwhichpercentageincrease": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageappliedonoutstandingsharesofcommonstockforautomaticallyincreaseoneachyear": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "12 months",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "10 years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionvestingterm": "through 2026",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationterm": "through 2032",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.23,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.4,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 5000000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0167,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.04360000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.8658,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.951,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 468335,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 180639,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 12.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 9.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 6.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 173604,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 122193,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 425000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 11.68,
    "leaseagreementcommencementdate": "May 1, 2022 ",
    "areaofofficespaceforlease": 11201,
    "leaseexpirationdate1": "April 30, 2025",
    "operatingleasebaserentexpense": 104000000,
    "operatingleaseliability": 1526000,
    "operatingleaseweightedaverageremainingleaseterm1": 4.6,
    "operatingleaseweightedaveragediscountratepercent": 0.0625,
    "financeleaserightofuseassetamortization": 4000,
    "operatingleasecost": 369000,
    "shorttermleasecost": 7000,
    "operatingleaseexpense": 376000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 383000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 392000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 372000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearthree": 613000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1760000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 234000,
    "deferredfinancecostsnet": 4300000,
    "debtinstrumentcarryingamount": 3800000,
    "interestexpensedebt": 2200000,
    "amortizationoffinancingcosts": 600000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -5142000,
    "incometaxreconciliationstateandlocalincometaxes": -955000,
    "incometaxreconciliationpermanentitems": 251000,
    "incometaxreconciliationtaxcreditsresearch": 235000,
    "incometaxreconciliationchangeinenactedtaxrate": 4637000,
    "incometaxreconciliationotheradjustments": 127000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1317000,
    "deferredtaxassetsoperatinglosscarryforwards": 29771000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3704000,
    "deferredtaxassetstaxcreditcarryforwards": 2615000,
    "deferredtaxassetssection174capitalization": 2465000,
    "deferredtaxassetsamortization": 780000,
    "deferredtaxassetsaccruedcompensation": 345000,
    "deferredtaxassetsleaseliabilities": 383000,
    "deferredtaxassetsother": 70000,
    "deferredtaxassetsgross": 40133000,
    "deferredtaxassetsvaluationallowance": 39732000,
    "deferredtaxassetsnet": 401000,
    "deferredtaxliabilitiesrightofuseassets": 362000,
    "deferredtaxliabilitiespropertyplantandequipment": 39000,
    "deferredincometaxliabilities": 401000,
    "operatinglosscarryforwards": 120700000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "equitymethodinvestmentownershippercentage": 0.5,
    "equitymethodinvestmentownershipperiod": "three-year",
    "contractwithcustomerliability": 50000000,
    "billedcollaborationrevenue": 900000,
    "unbilledcollaborationrevenue": 100000,
    "milestonepaymentrecognized": 8000000
  },
  {
    "date": "2021-12-30",
    "symbol": "VRCA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": " December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VRCA",
    "entityinteractivedatacurrent": "Yes",
    "entityregistrantname": "Verrica Pharmaceuticals Inc.",
    "entitycentralindexkey": 1660334,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "December 31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "true",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-38529",
    "entitytaxidentificationnumber": "46-3137900",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "The Nasdaq Stock Market, LLC",
    "documentannualreport": "☒ ",
    "documenttransitionreport": "☐ ",
    "entityincorporationstatecountrycode": "Delaware",
    "entityaddressaddressline1": "44 West Gay Street",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "West Chester",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19380,
    "cityareacode": 484,
    "localphonenumber": "453-3300",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Philadelphia, PA",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": 15752000,
    "availableforsalesecuritiesdebtsecurities": 39345000,
    "prepaidexpenseandotherassetscurrent": 3974000,
    "assetscurrent": 74328000,
    "propertyplantandequipmentnet": 3894000,
    "operatingleaserightofuseasset": 1608000,
    "otherassetsnoncurrent": 295000,
    "assets": 80125000,
    "accountspayablecurrent": 845000,
    "accruedexpensesandothercurrentliabilities": 3266000,
    "operatingleaseliabilitycurrent": 245000,
    "financeleaseliabilitycurrent": 6000,
    "shorttermborrowings": 40000000,
    "liabilitiescurrent": 46055000,
    "operatingleaseliabilitynoncurrent": 1449000,
    "financeleaseliabilitynoncurrent": 16000,
    "liabilities": 47520000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 171597000,
    "retainedearningsaccumulateddeficit": -138966000,
    "accumulatedothercomprehensiveincomelossnetoftax": -29000,
    "stockholdersequity": -29000,
    "liabilitiesandstockholdersequity": 80125000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "treasurystockshares": 848859,
    "revenuefromcontractwithcustomerexcludingassessedtax": 12000000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseMember",
    "researchanddevelopmentexpense": 2300000,
    "generalandadministrativeexpense": 26979000,
    "operatingexpenses": 42908000,
    "operatingincomeloss": -30908000,
    "investmentincomeinterest": 123000,
    "interestexpense": 4295000,
    "nonoperatingincomeexpense": -4172000,
    "netincomeloss": -35080000,
    "earningspersharebasicanddiluted": -1.3,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -30000,
    "comprehensiveincomenetoftax": -35110000,
    "sharesissued": 105144,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6053000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluenewissues": 28118000,
    "stockissuedduringperiodvaluestockoptionsexercised": 558000,
    "stockissuedduringperiodsharesstockoptionsexercised": 44041,
    "profitloss": -35080000,
    "allocatedsharebasedcompensationexpense": 4540000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -66000,
    "depreciation": 244000,
    "noncashinterestexpense": 1442000,
    "operatingleaserightofuseassetamortization": 228000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 543000,
    "increasedecreaseinaccountspayable": 497000,
    "increasedecreaseinaccruedexpensesandothercurrentliabilities": 208000,
    "increasedecreaseindeferredrevenue": -500000,
    "increasedecreaseinoperatingleaseliability": -197000,
    "netcashprovidedbyusedinoperatingactivities": -27582000,
    "paymentstoacquiremarketablesecurities": 68914000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 69000000,
    "paymentstoacquirepropertyplantandequipment": 883000,
    "increasedecreaseindepositsinvestingactivity": 201000,
    "netcashprovidedbyusedininvestingactivities": -998000,
    "proceedsfromstockoptionsexercised": 558000,
    "proceedsfromissuanceofcommonstock": 28118000,
    "proceedsfromdebtnetofissuancecosts": 4975000,
    "financeleaseprincipalpayments": 5000,
    "netcashprovidedbyusedinfinancingactivities": 33646000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 5066000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 15752000,
    "noncashorpartnoncashacquisitionvalueofassetsacquired1": 255000,
    "marketablesecuritiesunrealizedgainloss": -30000,
    "interestpaidnet": 2850000,
    "lineofcredit": 5000000,
    "cashcashequivalentsandshortterminvestments": 70400000,
    "numberofoperatingsegments": 1,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "did not have an impact ",
    "propertyplantandequipmentusefullife": "3 years",
    "propertyplantandequipmentestimatedusefullives": "Lease Term",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 425000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 54631000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 29000,
    "propertyplantandequipmentgross": 4148000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 254000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 24000,
    "employeerelatedliabilitiescurrent": 1667000,
    "accruedclinicaltrialanddrugdevelopmentcurrent": 613000,
    "accruedprofessionalfeescurrent": 406000,
    "interestpayablecurrent": 250000,
    "accruedconstructioninprocesscurrent": 131000,
    "accruedmachineryandequipment": 124000,
    "otheraccruedexpensesandothercurrentliabilities": 75000,
    "longtermpurchasecommitmentperiod": "five-year",
    "purchasecommitmentamountcommitted": 800000,
    "purchasecommitmentprepayment": 800000,
    "commonstockvotingrights": "one",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofyearsforwhichpercentageincrease": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageappliedonoutstandingsharesofcommonstockforautomaticallyincreaseoneachyear": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "12 months",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "10 years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionvestingterm": "through 2025",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationterm": "through 2031",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.72,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 11700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.9,
    "treasurystockacquiredaveragecostpershare": 0.0001714,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 5000000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 13.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0076,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0124,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.8714000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8939,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 462617,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 174219,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.05,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 12.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 13.87,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 13.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 8.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 6.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 425000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 11.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 12.29,
    "operatingleaseexpirationmonthandyear": "May 2021",
    "leaseexpirationdate1": "September 1, 2027",
    "operatingleasebaserentexpense": 2400000,
    "operatingleaseliability": "null",
    "financingleasesexpirationyear": 2025,
    "financingvehicleleasenet": 22000,
    "operatingleaseweightedaverageremainingleaseterm1": 5.7,
    "financeleaseweightedaverageremainingleaseterm1": 3.3,
    "operatingleaseweightedaveragediscountratepercent": 0.0625,
    "financeleaseweightedaveragediscountratepercent": 0.0435,
    "financeleaserightofuseassetamortization": 5000,
    "financeleaseexpense": 5000,
    "operatingleasecost": 346000,
    "shorttermleasecost": 21000,
    "operatingleaseexpense": 367000,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 7000,
    "financeleaseliabilitypaymentsdueyeartwo": 7000,
    "financeleaseliabilitypaymentsdueyearthree": 8000,
    "financeleaseliabilitypaymentsdueyearfour": 2000,
    "financeleaseliabilitypaymentsdue": 24000,
    "financeleaseliabilityundiscountedexcessamount": 2000,
    "financeleaseliability": 22000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 344000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 349000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 355000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 360000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfour": 613000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2021000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 327000,
    "debtinstrumentpaymentterms": "The Term Loans will be interest-only through March 31, 2022, followed by 24 equal monthly payments of principal and interest. ",
    "debtinstrumentinterestrateterms": "The Revolving Loans will bear interest at a floating per annum rate equal to the greater of (i) 6.00% and (ii) the sum of (a) the prime rate reported in The Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue, plus (b) 1.25%.",
    "debtinstrumentcovenantcompliance": "As of December 31, 2021 the Company is in compliance with all covenants.",
    "deferredfinancecostsnet": 100000,
    "debtinstrumentcarryingamount": 40000000,
    "interestexpensedebt": 4300000,
    "interestexpensedebtexcludingamortization": 2900000,
    "amortizationoffinancingcosts": 1400000,
    "accruedfinalpaymentfee": 3750000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 2057000,
    "debtcurrent": 41693000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 15000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 20000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 5000000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -7367000,
    "incometaxreconciliationstateandlocalincometaxes": -2697000,
    "incometaxreconciliationpermanentitems": 282000,
    "incometaxreconciliationtaxcreditsresearch": -26000,
    "incometaxreconciliationotheradjustments": 205000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 9551000,
    "deferredtaxassetsoperatinglosscarryforwards": 31514000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3321000,
    "deferredtaxassetstaxcreditcarryforwards": 2380000,
    "deferredtaxassetsamortization": 678000,
    "deferredtaxassetsaccruedcompensation": 479000,
    "deferredtaxassetsleaseliabilities": 497000,
    "deferredtaxassetsother": 16000,
    "deferredtaxassetsgross": 38885000,
    "deferredtaxassetsvaluationallowance": 38414000,
    "deferredtaxassetsnet": 471000,
    "deferredtaxliabilitiesrightofuseassets": 466000,
    "deferredtaxliabilitiespropertyplantandequipment": 5000,
    "deferredincometaxliabilities": 471000,
    "operatinglosscarryforwards": 110900000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "operatinglosscarryforwardsfederalandstateresearchanddevelopmentcarryforwards": 2400000,
    "equitymethodinvestmentownershippercentage": 0.5,
    "equitymethodinvestmentownershipperiod": "three-year",
    "deferredincometaxexpensebenefit": -2400000
  },
  {
    "date": "2020-12-30",
    "symbol": "VRCA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VRCA",
    "entityinteractivedatacurrent": "Yes",
    "entityregistrantname": "Verrica Pharmaceuticals Inc.",
    "entitycentralindexkey": 1660334,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-38529",
    "entitytaxidentificationnumber": "46-3137900",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "The Nasdaq Stock Market, LLC",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "entityaddressaddressline1": "10 North High Street",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "West Chester",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19380,
    "cityareacode": 484,
    "localphonenumber": "453-3300",
    "cashandcashequivalentsatcarryingvalue": 10686000,
    "availableforsalesecuritiesdebtsecurities": 43175000,
    "prepaidexpenseandotherassetscurrent": 2180000,
    "assetscurrent": 67650000,
    "propertyplantandequipmentnet": 3102000,
    "operatingleaserightofuseasset": 1836000,
    "otherassetsnoncurrent": 1566000,
    "assets": 74154000,
    "accountspayablecurrent": 348000,
    "accruedexpensesandothercurrentliabilities": 3114000,
    "operatingleaseliabilitycurrent": 198000,
    "deferredrevenuecurrent": 500000,
    "debtcurrent": 35315000,
    "liabilitiescurrent": 39475000,
    "operatingleaseliabilitynoncurrent": 1693000,
    "liabilities": 41168000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 136868000,
    "retainedearningsaccumulateddeficit": -103886000,
    "accumulatedothercomprehensiveincomelossnetoftax": 1000,
    "stockholdersequity": 1000,
    "liabilitiesandstockholdersequity": 74154000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "treasurystockshares": 848859,
    "researchanddevelopmentexpense": 300000,
    "generalandadministrativeexpense": 24508000,
    "operatingexpenses": 40181000,
    "operatingincomeloss": -40181000,
    "investmentincomeinterest": 521000,
    "interestexpense": 3033000,
    "otherexpenses": 1000,
    "nonoperatingincomeexpense": -2513000,
    "netincomeloss": -42694000,
    "earningspersharebasicanddiluted": -1.71,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -19000,
    "comprehensiveincomenetoftax": -42713000,
    "sharesissued": 105144,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 9821000,
    "stockrepurchasedandretiredduringperiodshares": -424429,
    "stockissuedduringperiodvaluestockoptionsexercised": 453000,
    "stockissuedduringperiodsharesstockoptionsexercised": 58549,
    "stockholdersequityrepaymentofsubscriptionreceivable": 410000,
    "profitloss": -42694000,
    "allocatedsharebasedcompensationexpense": 9008000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 138000,
    "depreciation": 43000,
    "noncashinterestexpenseondebt": 940000,
    "operatingleaserightofuseassetamortization": 186000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -786000,
    "increasedecreaseinaccountspayable": -838000,
    "increasedecreaseinaccruedliabilities": 1394000,
    "increasedecreaseindeferredrevenue": 500000,
    "increasedecreaseinoperatingleaseliability": -207000,
    "netcashprovidedbyusedinoperatingactivities": -30207000,
    "paymentstoacquiremarketablesecurities": 71738000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 69849000,
    "paymentstoacquirepropertyplantandequipment": 1470000,
    "increasedecreaseindepositsinvestingactivity": 221000,
    "netcashprovidedbyusedininvestingactivities": -3580000,
    "proceedsfromstockoptionsexercised": 453000,
    "proceedsfromissuanceofdebtnet": 34460000,
    "paymentsofdebtissuancecosts": 91000,
    "repaymentofsubscriptionreceivable": -410000,
    "netcashprovidedbyusedinfinancingactivities": 35232000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 1445000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 10686000,
    "noncashorpartnoncashacquisitionvalueofassetsacquired1": 318000,
    "rightofuseassetobtainedinexchangeforleaseobligation": 1910000,
    "marketablesecuritiesunrealizedgainloss": -19000,
    "interestpaidnet": 1875000,
    "debtissuancecostsincurredduringnoncashorpartialnoncashtransaction": 100000,
    "lineofcredit": 35000000,
    "numberofoperatingsegments": 1,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "operatingleaseliability": "null",
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Lease term",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 475000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 54783000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 2000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "propertyplantandequipmentgross": 3229000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 127000,
    "relatedpartytransactionsellinggeneralandadministrativeexpensesfromtransactionswithrelatedparty": 60000,
    "employeerelatedliabilitiescurrent": 1338000,
    "accruedclinicaltrialanddrugdevelopmentcurrent": 611000,
    "accruedprofessionalfeescurrent": 447000,
    "accruedconstructioninprocesscurrent": 277000,
    "interestpayablecurrent": 219000,
    "otheraccruedexpensesandothercurrentliabilities": 222000,
    "longtermpurchasecommitmentperiod": "P5Y",
    "contractualobligation": 29375,
    "consultingservicefeeperhour": 300,
    "commonstockvotingrights": "one",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "stockissuedduringperiodsharesnewissues": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofyearsforwhichpercentageincrease": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageappliedonoutstandingsharesofcommonstockforautomaticallyincreaseoneachyear": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionvestingterm": "through 2024",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationterm": "through 2030",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 10700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "treasurystockacquiredaveragecostpershare": 0.0001714,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 424430,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 11.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 250000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 5600000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0027,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0167,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.7671,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8597,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 125377,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 22667,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.73,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.78,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 8.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 475000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 499429,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 11.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 2.64,
    "operatingleaseexpirationmonthandyear": "May 2021",
    "leaseexpirationdate1": "September 1, 2027",
    "operatingleasebaserentexpense": 2400000,
    "operatingleaseweightedaverageremainingleaseterm1": 6.7,
    "operatingleaseweightedaveragediscountratepercent": 0.0625,
    "operatingleasecost": 164000,
    "shorttermleasecost": 22000,
    "operatingleasesrentexpensenet": 186000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 312000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 343000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 349000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 355000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 360000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 612000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2331000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 440000,
    "debtinstrumentdescription": "The Term B2 Loan will be available for draw if the Company receives approval from the FDA of the NDA for VP-102 prior to September 30, 2021 and the Company maintains compliance with the minimum liquidity covenant until the earlier of September 30, 2021 or the occurrence of an event of default.",
    "debtinstrumentpaymentterms": "The Term Loans will be interest-only through March 31, 2022, followed by 24 equal monthly payments of principal and interest; provided that if the Company draws the Term B Loan, the Term Loans will be interest-only through September 30, 2022, followed by 18 equal monthly payments of principal and interest.",
    "debtinstrumentinterestrateterms": "The Revolving Loans will bear interest at a floating per annum rate equal to the greater of (i) 6.00% and (ii) the sum of (a) the prime rate reported in The Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue, plus (b) 1.25%.",
    "debtinstrumentcovenantcompliance": "As of December 31, 2020 the Company is in compliance with all covenants.",
    "deferredfinancecostsnet": 100000,
    "debtinstrumentcarryingamount": 35000000,
    "interestexpensedebt": 3000000,
    "interestexpensedebtexcludingamortization": 2100000,
    "amortizationoffinancingcosts": 900000,
    "shorttermborrowings": 35000000,
    "accruedfinalpaymentfee": 3750000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 3435000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 13125000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 17500000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 4375000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -8966000,
    "incometaxreconciliationstateandlocalincometaxes": -2938000,
    "incometaxreconciliationpermanentitems": 1283000,
    "incometaxreconciliationtaxcreditsresearch": 2405000,
    "incometaxreconciliationotheradjustments": -2000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 13028000,
    "deferredtaxassetsoperatinglosscarryforwards": 23881000,
    "deferredtaxassetsinprocessresearchanddevelopment": 2405000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2170000,
    "deferredtaxassetsleaseliabilities": 549000,
    "deferredtaxassetsaccruedcompensation": 388000,
    "deferredtaxassetsother": 12000,
    "deferredtaxassetsgross": 29405000,
    "deferredtaxassetsvaluationallowance": 28863000,
    "deferredtaxassetsnet": 542000,
    "deferredtaxliabilitiesrightofuseassets": 532000,
    "deferredtaxliabilitiespropertyplantandequipment": 10000,
    "deferredincometaxliabilities": 542000,
    "operatinglosscarryforwards": 84100000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "operatinglosscarryforwardsfederalandstateresearchanddevelopmentcarryforwards": 2400000,
    "equitymethodinvestmentownershippercentage": 0.5,
    "equitymethodinvestmentownershipperiod": "P3Y",
    "deferredincometaxexpensebenefit": -2400000,
    "deferredrevenue": 500000,
    "upfrontlicensefee": 300000
  },
  {
    "date": "2019-12-30",
    "symbol": "VRCA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VRCA",
    "entityinteractivedatacurrent": "Yes",
    "entityregistrantname": "Verrica Pharmaceuticals Inc.",
    "entitycentralindexkey": 1660334,
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entityfilenumber": "001-38529",
    "entitytaxidentificationnumber": "46-3137900",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "10 North High Street",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "West Chester",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19380,
    "cityareacode": 484,
    "localphonenumber": "453-3300",
    "cashandcashequivalentsatcarryingvalue": 9241000,
    "availableforsalesecuritiesdebtsecurities": 13457000,
    "prepaidexpenseandotherassetscurrent": 2966000,
    "assetscurrent": 64983000,
    "propertyplantandequipmentnet": 2090000,
    "operatingleaserightofuseasset": 111000,
    "depositsassetsnoncurrent": 1240000,
    "assets": 68424000,
    "accountspayablecurrent": 1185000,
    "accruedliabilitiescurrent": 2036000,
    "operatingleaseliabilitycurrent": 130000,
    "liabilitiescurrent": 3351000,
    "operatingleaseliabilitynoncurrent": 58000,
    "liabilities": 3409000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 126594000,
    "stockholdersequitynotesubscriptionsreceivable": 410000,
    "retainedearningsaccumulateddeficit": -61192000,
    "accumulatedothercomprehensiveincomelossnetoftax": 20000,
    "stockholdersequity": 20000,
    "liabilitiesandstockholdersequity": 68424000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 25912137,
    "commonstocksharesoutstanding": 25786330,
    "treasurystockshares": 848859,
    "researchanddevelopmentexpense": 15436000,
    "generalandadministrativeexpense": 14644000,
    "operatingexpenses": 30080000,
    "operatingincomeloss": -30080000,
    "investmentincomeinterest": 1877000,
    "otherexpenses": 4000,
    "nonoperatingincomeexpense": 1873000,
    "netincomeloss": -28207000,
    "earningspersharebasicanddiluted": -1.13,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 24897889,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 37000,
    "comprehensiveincomenetoftax": -28170000,
    "sharesissued": 105144,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3333000,
    "stockissuedduringperiodvaluestockoptionsexercised": 423000,
    "stockissuedduringperiodsharesstockoptionsexercised": 102237,
    "subscriptionreceivable": -410000,
    "subscriptionsharesreceivable": 27329,
    "cumulativeeffectofnewaccountingstandardupdateinperiodofadoption": 98000,
    "stockissuedduringperiodsharesnewissues": 2198198,
    "profitloss": -28207000,
    "allocatedsharebasedcompensationexpense": 2724000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 1063000,
    "depreciation": 64200,
    "operatingleaserightofuseassetamortization": 193000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1621000,
    "increasedecreaseinaccountspayable": 263000,
    "increasedecreaseinaccruedliabilities": -213000,
    "increasedecreaseinaccountspayableandaccruedexpensesrelatedparty": -38000,
    "increasedecreaseinoperatingleaseliability": -119000,
    "netcashprovidedbyusedinoperatingactivities": -27408000,
    "paymentstoacquiremarketablesecurities": 89854000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 117715000,
    "paymentstoacquirepropertyplantandequipment": 682000,
    "increasedecreaseindepositsinvestingactivity": 1224000,
    "netcashprovidedbyusedininvestingactivities": 25955000,
    "proceedsfromstockoptionsexercised": 423000,
    "netcashprovidedbyusedinfinancingactivities": 423000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1030000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 9241000,
    "marketablesecuritiesunrealizedgainloss": 37000,
    "noncashorpartnoncashsubscriptionreceivableonexerciseofoptions": 410000,
    "noncashorpartnoncashacquisitionfixedassetsacquired1": 733000,
    "stockholdersequityreversestocksplit": "No fractional shares were issued in connection with the stock split.",
    "numberofoperatingsegments": 1,
    "operatingleaseliability": 188000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Lease term",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1148859,
    "availableforsaledebtsecuritiesamortizedcostbasis": 52756000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 21000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "propertyplantandequipmentgross": 2174000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 84000,
    "relatedpartytransactionsellinggeneralandadministrativeexpensesfromtransactionswithrelatedparty": 252000,
    "employeerelatedliabilitiescurrent": 1195000,
    "accruedclinicaltrialanddrugdevelopmentcurrent": 733000,
    "accruedprofessionalfeescurrent": 89000,
    "otheraccruedliabilitiescurrent": 19000,
    "longtermpurchasecommitmentperiod": "P5Y",
    "purchasecommitmentamountcommitted": 1800000,
    "purchasecommitmentprepayment": 1100000,
    "contractualobligation": 29375,
    "consultingservicefeeperhour": 300,
    "commonstockvotingrights": "one",
    "treasurystockacquiredaveragecostpershare": 0.0001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The restricted stock units vest 50% upon receipt of regulatory approval of the Company’s new drug application for VP-102 for the treatment of molluscum (the “Approval Date”) and 50% shall vest on the one year anniversary of the Approval Date subject to the holders’ continuous service through each applicable date.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P12M",
    "commonstockcapitalsharesreservedforfutureissuance": 3738199,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofyearsforwhichpercentageincrease": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageappliedonoutstandingsharesofcommonstockforautomaticallyincreaseoneachyear": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2199325,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionvestingterm": "Through 2023",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationterm": "Through 2029",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.84,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 8700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 27329,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 5000000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 11.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0142,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0256,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y11M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.721,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.783,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1914545,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 830918,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 344019,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 616994,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.14,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 7.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 12953956,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 5362458,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 848859,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.33,
    "operatingleaseexpirationmonthandyear": "2021-05",
    "lesseeoperatingleasetermofcontract": "P7Y",
    "operatingleasebaserentexpense": 1300000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y4M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.0675,
    "operatingleasecost": 211000,
    "shorttermleasecost": 17000,
    "operatingleasesrentexpensenet": 228000,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 139000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyeartwo": 58000,
    "lesseeoperatingleaseliabilitypaymentsdue": 197000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 9000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -5923000,
    "incometaxreconciliationstateandlocalincometaxes": -2312000,
    "incometaxreconciliationpermanentitems": 70000,
    "incometaxreconciliationotheradjustments": -285000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 8450000,
    "deferredtaxassetsoperatinglosscarryforwards": 14370000,
    "deferredtaxassetsother": 1483000,
    "deferredtaxassetsgross": 15853000,
    "deferredtaxassetsvaluationallowance": 15835000,
    "deferredtaxassetsnet": 18000,
    "deferredtaxliabilitiespropertyplantandequipment": 18000,
    "deferredincometaxliabilities": 18000,
    "operatinglosscarryforwards": 50200000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "equitymethodinvestmentownershippercentage": 0.5,
    "equitymethodinvestmentownershipperiod": "P3Y",
    "unrecognizedtaxbenefits": 1500000,
    "debtinstrumentpaymentterms": "The Term Loans will be interest-only through March 31, 2022, followed by 24 equal monthly payments of principal and interest; provided that if the Company draws the Term B Loan, the Term Loans will be interest-only through September 30, 2022, followed by 18 equal monthly payments of principal and interest.",
    "debtinstrumentinterestrateterms": "The Revolving Loans will bear interest at a floating per annum rate equal to the greater of (i) 6.00% and (ii) the sum of (a) the prime rate reported in The Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue, plus (b) 1.25%."
  }
]